Pharmacy |
| ||
|
SINEMET Generic Carbidopa Levodopa |
|
| ||
Home » Prescription Drugs 15 » SINEMET Generic Carbidopa Levodopa Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:SINEMET* (Carbidopa-Levodopa) is a combination of carbidopa and levodopa for the treatment of Parkinson's disease and syndrome. SINEMET is indicated in the treatment of the symptoms of idiopathic Parkinson's disease (paralysis agitans) post-encephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication. SINEMET is indicated in these conditions to permit the administration of lower doses of levodopa with reduced nausea and vomiting with more rapid dosage titration with a somewhat smoother response and with supplemental pyridoxine (vitamin B6).In some patients a somewhat smoother antiparkinsonian effect results from therapy with SINEMET than with levodopa Buy SINEMET Generic Carbidopa Levodopa and other Prescription Drugs 15 products online at Medstore. 3594
About SINEMET Generic Carbidopa Levodopa: Product Type: Prescription Drugs 15 SINEMET ( Generic Carbidopa & Levodopa ) SINEMET (Generic Carbidopa & Levodopa) Generic Carbidopa & Levodopa 25/250mg 30 Tabs Generic Carbidopa & Levodopa SINEMET
View more Prescription Drugs 15 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
